Overview
Efficacy of Platelet- and Extracellular Vesicle-rich Plasma in Chronic Postsurgical Temporal Bone Inflammations
Status:
Completed
Completed
Trial end date:
2020-10-14
2020-10-14
Target enrollment:
0
0
Participant gender:
All
All
Summary
This clinical study evaluates the efficacy of the autologous blood-derived product called platelet- and extracellular vesicle-rich plasma (PVRP) for the treatment of chronically inflamed post-surgical temporal bone cavities. Half of the participants will be treated with platelet- and extracellular vesicle-rich plasma and another half with standard nonsurgical measures.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University Medical Centre LjubljanaCollaborators:
University of Ljubljana
University of Ljubljana, Faculty of Medicine
Criteria
Inclusion Criteria:- chronic otitis media, defined as a presence of at least 1 of the following: visible
ear discharge, indirect signs of ear discharge (e.g. on a pillow, clothes), ear
itching, the sensation of ear fullness, clinical signs of acute exacerbation of
chronic otitis media during an otomicroscopic examination.
- non-cholesteatomatous chronic otitis media despite prior standard conservative
treatment
- non-cholesteatomatous chronic otitis media despite prior surgical treatment
Exclusion Criteria:
- the presence or suspicion of cholesteatoma
- infection of venepuncture site
- pregnancy
- breastfeeding
- long-term treatment with antimicrobial drugs
- long-term treatment with immunosuppressant drugs
- the presence of systemic infectious disease
- the presence of an autoimmune disease
- the presence of cancer
- receiving other types of experimental treatment for chronic otitis media